OR WAIT 15 SECS
© 2020 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2020 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
August 01, 2012
The manufacturing capacity-sharing model in biologics and Merck & Co. and MedImmune ushers in a new paradigm of "co-opetition".
The author provides results and commentary on a survey analyzing outsourcing strategies, practices, challenges, and outcomes in the selection of a CRO.
An examination of the current and projected market for biosimilars, development costs for biosimilars compared with small-molecule generic drug, and partnerships in biosimilars.
The author discusses how a CDMO helps in gaining process understanding and in developing robust, high-quality products and processes.
The authors highlight costs, benefits, and implementation success factors across first, second, and third generations of facility management outsourcing contracts.
AMRI, a contract research and manufacturing organization, discusses its adaption of an insourcing model with Eli Lilly.
Annual survey shows strong growth for service providers and promises to continue into 2013.